Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Multiple genetic factors in olanzapine-induced weight gain in schizophrenia patients: a cohort study.

The Journal of clinical psychiatry - 1 Sept 2008

Ujike Hiroshi, Nomura Akira, Morita Yukitaka, Morio Akiko, Okahisa Yuko, Kotaka Tatsuya, Kodama Masafumi, Ishihara Takeshi, Kuroda Shigetoshi

Abstract excerpt

OBJECTIVE: One of the clinically significant adverse effects of olanzapine treatment is weight gain, which shows substantial inter-individual differences and may be influenced by genetic variation. The aim of this investigation was identification of genetic risk factors associated with olanzapine-induced weight gain. METHOD: Inpatients with DSM-IV-TR schizophrenia (N = 164) were administered olanzapine for 8 to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Benzodiazepines

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Heterotrimeric GTP-Binding Proteins

Share to Olanzapine

Share to Receptor, Serotonin, 5-HT2A

Share to Receptor, Serotonin, 5-HT2C

Share to Receptors, Adrenergic, beta-3

Share to Weight Gain

Source

Identifiers

PMID: 19193342
DOI: 10.4088/jcp.v69n0909

Genes

ADRB3
GNB3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Multiple genetic factors in olanzapine-induced weight gain in schizophrenia patients: a cohort study.PMID 19193342Read ↗

A2BP1 gene polymorphisms association with olanzapine-induced weight gain.Semantic proximity Read ↗

Leptin and leptin receptor gene polymorphisms and increases in body mass index (BMI) from olanzapine treatment in persons with schizophrenia.Semantic proximity Read ↗

Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications.Semantic proximity Read ↗

Genetic Correlates of Olanzapine-Induced Weight Gain in Schizophrenia Subjects from North India: Role of Metabolic Pathway GenesSemantic proximity Read ↗

HTR2C polymorphisms, olanzapine-induced weight gain and antipsychotic-induced metabolic syndrome in schizophrenia patients: a meta-analysis.Semantic proximity Read ↗

Genetics of antipsychotic treatment emergent weight gain in schizophrenia.Semantic proximity Read ↗

Pharmacogenomic associations with weight gain in olanzapine treatment of patients without schizophrenia.Semantic proximity Read ↗

Genetics of antipsychotic-induced weight gain: update and current perspectives.Semantic proximity Read ↗

Genetics of second-generation antipsychotic and mood stabilizer-induced weight gain in bipolar disorder: common and specific effects of key regulators of fat-mass homoeostasis genes.Semantic proximity Read ↗

Role of 5-HT2C receptor gene variants in antipsychotic-induced weight gainSemantic proximity Read ↗

Lack of association between the -759C/T polymorphism of the 5-HT2C receptor gene and olanzapine-induced weight gain among Korean schizophrenic patients.Semantic proximity Read ↗

GIPR Gene Polymorphism and Weight Gain in Patients With Schizophrenia Treated With Olanzapine.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.